AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Dr. Chris Palmer: Diet & Nutrition for Mental Health
Huberman Lab
Semagluetide and GLP-1 Related Compounds - What Are Your Thoughts?
There's a new class of drugs that I think initially were developed to treat diabetes but are now being evaluated for their efficacy to treat obesity. These are the semagluetide drugs that are involved in, they tap into these glucagon-related GLP-1 pathways and this is a story that we've talked about a little bit on the podcast before. The real answer is I am not at all an expert on these medications. They obviously adjust the way that glucose and insulin are managing energy both in the body and the brain and can produce weight loss. But a good logical shift in diet and exercise could achieve similar weight loss but a lot of people just won't do that.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode